Prevention and control of viral hepatitis in France: Lessons learnt and the way forward

Veyrier-Du-Lac, France, November 18-19, 2004

- Meeting Programme -

Thursday, November 18, 2004

Session 1: Opening and objectives

Chair: Nicole Guérin and Nedret Emiroglu

09.00 - 09.30

• Welcome
• Introduction of the participants
• Objectives of the meeting:
  1. Update of the epidemiological situation on viral hepatitis in France;
  2. Overview of surveillance systems for infectious diseases and adverse events following vaccination in France;
  3. Overview of the research activities on viral hepatitis in France;
  4. Evaluation of current prevention and control measures on viral hepatitis in France;
  5. Lessons learnt from the experience in France: successes, problems and barriers to overcome, and the way forward.
• Review of the meeting programme
• Pre-meeting document 469 Kb (.pdf)

Session 2: The health-care system in France

Chair: Nicole Guérin and Nedret Emiroglu

09.30 - 09.55
Organisation, preventive health-care system, and financement 418 Kb (.pdf)
Martine Le Quellec-Nathan, France

09.55 - 10.20
French national programme for viral hepatitis prevention and control 353 Kb (.pdf)
Anne-Marie Jullien-Depradeux, France

10.20 - 10.40 Coffee break

Chair: Françoise Roudot-Thoraval and Johannes Hallauer

10.40 - 11.05
Research on viral hepatitis: organisation and funding 676 Kb (.pdf)
Jean-Michel Pawlotsky, Créteil, France

11.05 - 11.30
HBV immunisation policies 159 Kb (.pdf)
Nicole Guérin, Antony, France

Session 3: Surveillance systems for viral hepatitis

Chair: Françoise Roudot-Thoraval and Johannes Hallauer

11.30 - 11.55
Overview of HAV, HBV, and HCV surveillance 237 Kb (.pdf)
Elisabeth Delarocque, France

11.55 - 12.20
Nosocomial HCV infections 184 Kb (.pdf)
Anne Carbonne, Paris, France

12.20 - 12.45
Surveillance of adverse events following immunisation 380 Kb (.pdf)
Alexis Jacquet, France

12.45 - 14.00 Lunch

Session 4:  Epidemiology of viral hepatitis in France

Chair: Daniel Lévy-Bruhl and Harold Margolis

14.00 - 14.30
Epidemiology of hepatitis A (including serological data in military) 852 Kb (.pdf)
Elisabeth Nicand, Val-de-Grâce, France

14.30 - 15.00
Epidemiology of hepatitis B 530 Kb (.pdf)
Fabien Zoulim, Lyon, France

15.00 - 15.30
Epidemiology of hepatitis C 427 Kb (.pdf)
Françoise Roudot-Thoraval, Paris, France

15.30 - 15.50 Coffee break

15.50 - 16.20
Regional registries (HBV and HCV, Côte d’Or and Doubs)
Patrick Hillon, Dijon, France

16.20 - 16.50
Prediction of hepatitis C burden due to cirrhosis and cancer 194 Kb (.pdf)
Sylvie Burban, France

Friday, November 19, 2004

Session 5: Prevention and control of viral hepatitis in France

Chair: Patrick Marcellin and Peter Grob

09.00 - 09.25
Prevention and residual risk of HCV, HIV, and HBV infection following blood transfusion 514 Kb (.pdf)
Syria Laperche, Paris, France

09.25 - 09.50
Injecting drug users and HCV infection: prevention strategies and results 493 Kb (.pdf)
Damien Lucidarme, France

09.50 - 10.15
Preventive measures for prisoners 398 Kb (.pdf)
Claire Wartelle, Aix-en-Provence, France

10.15 - 10.35 Coffee break

Session 6: Evaluation of viral hepatitis prevention and control measures - prospects

Chair: Daniel Dhumeaux and Daniel Lavanchy

10.35 - 11.00
French national programme for prevention and control of viral hepatitis: preliminary results 139 Kb (.pdf)
Patrick Marcellin, Paris, France

11.00 - 11.25
Impact of hepatitis B vaccine safety issues on vaccination strategies and their implementation in France 187 Kb (.pdf)
Daniel Lévy-Bruhl, Saint-Maurice, France

11.25 - 11.50
HBV and HCV infection in health-care workers 429 Kb (.pdf)
Yazdan Yazdanpanah, France

11.50 - 12.15
What still needs to be done
Jean-Claude Desenclos, Saint-Maurice, France

12.15 - 14.15 Lunch

Session 7: Conclusions

Chair: Jean-Claude Desenclos and André Meheus

14.15 - 15.30
Presentation of the VHPB meeting conclusions, including discussion 89 Kb (.pdf) Updated version since 12/12/04
Guido François, VHPB

15.30 Close of the meeting